Right ventricular fibrosis measured by cardiac MRI in patients with tetralogy of Fallot

• Conditions: Q21.3; I49.9; Tetralogy of Fallot; Cardiac arrhythmia, unspecified

• Registration Number: DRKS00021437
• Lead Sponsor: niversitäts-Herzzentrum Freiburg - Bad Krozingen, Klinik für Angeborene Herzfehler und Pädiatrische Kardiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-13
• Study Completion: 2023-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 17

Inclusion Criteria

Informed consent of the patient or guardian, Tetralogy of Fallot, no further severe cardiac defects, planned operation or catheter intervention

Exclusion Criteria

Cardiorespiratory instability, typical contraindications against MRI-measurements

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
T1 mapping values and calculated extracellular volume fraction (= fibrosis) in cardiac MRI of right ventricle

Secondary Outcome Measures

Name	Time	Method
Tissue phase mapping values in cardiac MRI as expression of right ventricular contractility<br>